13G Filing: Sabby Capital and Bioamber Inc. (BIOA)

Bioamber Inc. (NYSE:BIOA): Hal Mintz’s Sabby Capital filed an amended 13D.

You can check out Sabby Capital’s latest holdings and filings here.

Please follow Sabby Capital (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Sabby Capital or update its stock holdings.

Hal Mintz
Hal Mintz
Sabby Capital

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Sabby Healthcare Master Fund, Ltd 0 2,023,943 0 2,023,943 2,023,943 3.89%
Sabby Volatility Warrant Master Fund, Ltd 0 1,181,400 0 1,181,400 1,181,400 2.27%
Sabby Management 0 3,205,343 0 3,205,343 3,205,343 6.15%
Hal Mintz 0 3,205,343 0 3,205,343 3,205,343 6.15%
Hal Mintz
Hal Mintz
Sabby Capital

Page 1 of 9 – SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No.)*

BioAmber Inc.
(Name of Issuer)

Common Stock
(Title of Class of Securities)

09072Q106
(CUSIP Number)

August 31, 2017
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which
this Schedule is filed:

[_] Rule 13d-1(b)

[X] Rule 13d-1(c)

[_] Rule 13d-1(d)

__________
*The remainder of this cover page shall be filled out for a reporting
person’s initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall
not be deemed to be filed for the purpose of Section 18 of the Securities
Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
?
CUSIP No.
09072Q106

Follow Bioamber Inc. (NYSE:BIOA)